Atlas Trials

Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

Clinical trial NCT02670109 · UNKNOWN

Trial details

NCT number
NCT02670109
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Triple-Negative Invasive Breast CarcinomaResidual Tumor
Start date
2018-02-01
Primary completion
2020-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.